Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression
Status:
Unknown status
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The proposed project will investigate the effects of probiotics on anxiety and associated
psychological and physiological factors in humans. The therapeutic potential of probiotics
for reducing anxiety and other factors associated with a disrupted microbiome will be
assessed in a double-blind placebo-crossover design. Based on the research findings to date,
it is hypothesized that probiotics will reduce anxiety and depressive symptoms.